145 related articles for article (PubMed ID: 8929231)
1. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 14C-moxisylyte after percutaneous application in hairless rat.
Neau B; Roux J; Marty JP
Arzneimittelforschung; 1998 Jan; 48(1):34-8. PubMed ID: 9522028
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route.
Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L
Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
[TBL] [Abstract][Full Text] [Related]
10. Comparison of thymoxamine permeation between hairless rat and horse penile mucous membrane using an in vitro diffusion model.
Neau B; Lozano P; Gomond P; Roux J; Grislain L; Lambrey B
Skin Pharmacol; 1994; 7(3):121-9. PubMed ID: 8003334
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat].
Schieweck A; offchert HH; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566
[TBL] [Abstract][Full Text] [Related]
12. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
13. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [14C]E-4716 after single-dose administration in rats and dogs.
Serafini MT; Puig S; Pretel MJ; García A; Martínez L
Methods Find Exp Clin Pharmacol; 1997; 19(6):407-15. PubMed ID: 9385590
[TBL] [Abstract][Full Text] [Related]
17. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application.
Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ
Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
